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Crimean Congo Hemorrhagic Fever (CCHF) is a 
zoonotic disease caused by a virus transmitted by 
ticks; it can cause severe hemorrhagic fever out-
breaks (1, 2). CCHF is an arboviral disease highly 
Abstract 
Background: This study aimed at estimating the incidence, mortality, burden, and geographical distribution of 
Crimean Congo Hemorrhagic Fever (CCHF) using Disability Adjusted Life Years (DALYs) in Iran 2009-2015.  
Methods: CCHF-related DALYs was calculated using a method developed by WHO for the investigation of 
Global Burden of Diseases (GBD). DALYs was calculated through adding years of life lost due to premature 
death (YLLs) to years lived with disability (YLDs). To calculate YLD, the average duration of the disease and 
its disability weight were set at 25 d and 0.613, respectively. The data on the incidence and mortality were col-
lected from the CCHF surveillance system from the governmental section.  
Results: The highest and the lowest incidence rates of CCHF were observed in 2009 (122 cases) and 2010 (254 
cases), respectively. Moreover, the lowest and highest mortality rates were reported in 2009 (20 cases) and 2012 
(52 cases), respectively. The mean rate of fatality from CCHF observed between 2009 and 2015 was about 
21.1%. In addition, the lowest and highest DALYs were observed in 2009 (483 cases) and 2010 (1156 cases), 
respectively. CCHF incidence, DALYs, and mortality rate over the studied period were higher among males 
than females. CCHF-related DALYs did not have an equal distribution in all provinces of Iran; some provinces 
were suffering from a higher burden of the disease.  
Conclusion: It is recommended to improve the CCHF surveillance system, identify high-risk areas, practice 
early diagnosis and intervention, develop vaccines, control, and fight tick, and screen livestock to control and 
prevent the spread of this disease.   
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widespread around the world. It is an endemic 
disease in Africa, Asia, Middle East, and Eastern 
Europe (3, 4). Iran is also considered as an en-
demic area for CCHF disease. According to the 
WHO's 2017 report, Iran, Turkey, Uzbekistan, 
and Russia are among the countries with the 
highest rate of reported cases of CCHF (more 
than 50 cases per year) (5).  
Farmers, livestock workers, slaughterhouse staff, 
health personnel, and people living in endemic 
areas are at risk of CCHF (1). Currently, there is 
no safe and effective human vaccine for CCHF 
and it causes a high rate of mortality among peo-
ple. Its fatality rate can vary from 10% to 40% 
(2). Its fatality rate in countries like Kosovo and 
turkey, which are endemic areas for the disease, is 
25.5% and 5%-10%, respectively (6, 7). In recent 
years, mortality from this disease has also been 
reported in Sudan, Iraq, Iran, Pakistan, and Af-
ghanistan (2).  
CCHF is an important disease that may endanger 
the lives of many people, therefore, the WHO 
supports the measures adopted to improve its 
surveillance system, diagnostic capacities, and 
responses to the outbreaks in Europe, Asia, Mid-
dle East, and Africa so that they would become 
able to control the disease or combat it (1, 2).  
To preserve the international prestige and to con-
trol the high mortality rates, surveillance systems 
of countries pay more attention to some of the 
infectious diseases. CCHF is one of such diseases 
that require special attention to be controlled (3, 
4).  
In order to prevent and control CCHF, to take 
an appropriate response against CCHF, and to 
improve policy-making, it is necessary to provide 
proper and reliable epidemiological information. 
Burden of disease is one of the important types 
of information. Estimating the burden of CCHF 
makes it possible to compare it with the burden 
of other diseases and provides an opportunity to 
set it as an agenda for the health policy makers so 
that they pay more attention to this issue. In ad-
dition, estimating the burden of the disease at 
national and local levels helps to determine its 
epidemic status as well as its trend over time; it 
helps to identify areas where the disease may be a 
danger and threat for the public health. Despite 
the significance of this issue, no study has been 
conducted in this field. Moreover, sharing bor-
ders with countries such as Iraq, Turkey, Afghan-
istan, and Pakistan, considered as endemic areas 
of the disease, doubles the significance of con-
ducting this study.  
To depict a comprehensive picture of the disease, 
we aimed at estimating the burden of CCHF at 
national and provincial levels as well as its trend 




The data on Disability-Adjusted Life Years 
(DALYs) was used for calculating the burden of 
CCHF. DALYs is calculated through adding 
Years of Life Lost due to premature death 
(YLLs) to Years of Life Lost due to disability 
(YLDs) (8). 
 DALY= YLL+ YLD Equation [1] 
DALYs was calculated using the method devel-
oped by the WHO for investigating the GBD (9, 
10). We did not consider age weights in the calcu-
lations; however, a discount rate of 0.03 was ap-
plied for discounting health values in future years 
(9). YLD is calculated through multiplying annual 
incidence rate of CCHF by its average period and 
disability weight. In the present study, after hold-
ing an expert panel with infectious diseases spe-
cialists, the average period of the disease was set 
at 25 d. Moreover, the disability weight was set at 
0.613 (11).  
In addition, disease burden was calculated and 
reported by age, time, and place for all provinces 
of Iran. For each age group, the mean age of the 
group was considered as death age for patients 
died from CCHF. However, mean age of death 
for the two age groups of 0-1 and 1-5 was set at 
0.1 and 2.6, respectively. The life expectancy re-
maining for each age group was calculated using 
life tables of Iranians reported by the WHO. The 
data on the incidence and mortality from 2009 to 
2015 were obtained from the CCHF surveillance 
system in the Centre for Communicable Diseases 
Control (CCDC), Ministry of Health and Medical 
Education (MOHME). We considered both defi-
www.SID.ir
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nite and probable cases of CCHF when calculat-
ing DALYs of CCHF. The statistical data on the 
population of the country and its provinces dur-
ing the studied years was collected from 
Statistical Center of Iran (12). Data were analyzed 




Table 1 presents the incidence, mortality, and 
burden of CCHF by sex from 2009 to 2015. The 
lowest and the highest incidence of CCHF were 
observed in 2009 (122 cases) and 2010 (254 cas-
es), respectively. Its incidence among males was 
higher than that among females. Furthermore, 
over the studied period, the lowest and the high-
est mortality were observed in 2009 (20 cases) 
and 2012 (52 cases), respectively. The mortality 
was higher among males than females. The low-
est and highest DALYs were 483 and 1156, re-
spectively. The trends of CCHF incidence and 
mortality rate per 100,000 population by sex are 
presented in Fig. 1. Its fatality was 21.1% (272 
deaths out of 1289 cases of CCHF) over the 
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Table 1: Incidence, mortality and burden of CCHF by sex during 2009-2015 
 



















DALY per 100,000 
populations 
2015 123 47 0.22 35 498 226 724 0.92 
2014 97 43 0.18 36 441 318 759 0.98 
2013 127 55 0.24 48 565 450 1015 1.32 
2012 161 91 0.33 52 599 362 961 1.26 
2011 117 52 0.22 32 400 274 674 0.90 
2010 199 55 0.34 49 752 404 1156 1.56 
2009 86 36 0.17 20 323 160 483 0.66 
 
Figure 2 presents the trend and variations in 
CCHF burden per 100,000 population over the 
studied period. The trend of CCHF-related 
DALYs had some fluctuations over the studied 
years. It was 0.66 in 2009 and 0.92 in 2015. 
Figure 3 shows the share of YLL and YLD in 
general burden of CCHF over the studied period. 
In all the studied years, more than 98% of 
DALYs were attributed to YLL caused by 
CCHF, indicating the high fatality rate of the dis-
ease.  
Figure 4 shows the share of each sex in the bur-
den of CCHF in various age groups in 2015. The 
highest burden of the disease was observed in 
people aged 15-44 yr old. In general, disease bur-










Iran J Public Health, Vol. 48, Supple.1, Mar 2019, pp. 44-52 
48                                                                                                          Available at:    http://ijph.tums.ac.ir 
Fig. 3: Share of YLL and YLD in the burden of CCHF (DALYs) during 2009-2015 
 
 
Fig. 4: Share of each sex in the burden of CCHF (DALYs) in different age groups in 2015 
 
The provincial distribution of CCHF in 2010, 
2012, and 2015 is presented in Figs. 5-7. In 2010, 
Sistan and Baluchistan with a DALY of 
16.27/100000 population and Yazd with a 
DALY of 8.01/100000 population had the high-
est burden of CCHF. In addition, in 2012, the 
highest CCHF-related DALYs per 100000 popu-
lation were observed in Golestan (4.65), Yazd 
(4.23), Sistan and Baluchistan (3.66), and Fars 
(3.54). Moreover, the highest burden of CCHF 
was observed in Golestan and Kerman with 4.49 
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Based on the results of our study, CCHF inci-
dence did not have a stable trend between 2009 
and 2015. The lowest and highest incidence per 
100 000 population were 0.18 in 2009 (122 cases) 
and 0.52 in 2010 (254 cases), respectively. The 
absence of suitable human and animal vaccines 
for CCHF, sharing borders with countries suffer-
ing from endemic disease, and unknown aspects 
that affect the criteria for the outbreak of the dis-
ease can be considered as the main causes for the 
outbreak of the disease and the absence of a spe-
cific trend (reduction or increase) in CCHF in the 
country. According to a study, 534 confirmed 
cases with CCHF (Confirmed Case) have been 
www.SID.ir
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reported in Iran between 2000 and 2008. The 
lowest and highest number of cases were ob-
served in 2005 (18 cases) and 2008 (120 cases), 
respectively (13). 
In Kosovo, the incidence of CCHF between 1995 
and 2013 has not been steady (increasing or de-
creasing) and varied from zero to 2.2 (46 cases) per 
100,000 people (14). According to the Turkish 
Health Ministry's surveillance system, between 2000 
(150 cases) and 2007 (717 cases), the incidence of 
CCHF was increasing, with a total of 1820 new cas-
es diagnosed with CCHF (15). According to a re-
port by the WHO published in 2017, Turkey, Uz-
bekistan, Kazakhstan, Russia, and Iran have 50 or 
more cases of CCHF per year (5).  
Over the studied period, the incidence of the dis-
ease among males was more than that among 
females. In Iran, livestock husbandry is a more 
common job among males than among females, 
and the disease is more likely to occur in people 
who live and work near livestock. This finding is 
in line with the results of other studies in Iran 
and other countries (13, 15). 
Moreover, CCHF mortality rate had a descending 
trend over the studied period and the disease 
caused more deaths among males than females. 
In Iran, between 2000 and 2008, the mortality 
rate due to CCHF decreased (13). In Kosovo, 
between 1994 and 2013, the mortality from the 
disease has fallen from 2.39 to 0.69 per 100,000 
people (7, 14). 
In our study, the lowest and the highest case fa-
tality rate were 16.4% in 2009 and 26.4% in 2013. 
Overall, the mean fatality rate was 21.1% (272 
deaths per 1289 cases). In Kosovo, CCHF fatality 
rate changed from zero in 1995 to 50% in 2013 
(14). Furthermore, disease fatality rate was 5% 
(92 deaths per 1820 case) in Turkey between 
2000 and 2007 (15), 11.5% in Pakistan in 2010 
(16), and 25.5% in Kosovo between 1995 and 
2013 (14).  
Results of our study indicated that the trend of 
DALYs caused by CCHF is closely in line with 
the trend of mortality rate. CCHF DALYs re-
duced between 2012 and 2015, indicating the 
high and effective contribution of YLL (more 
than 98%) to the total DALYs caused by CCHF. 
In all the studied years, the burden of disease 
among males was more than that among females. 
In addition, in 2015, people aged 15-44 yr old 
had the highest share in DALYs. In Iran, the 
DALYs caused by CCHF was 367 (11). Based on 
our reviews, no similar study has been conducted 
in other countries.  
The high burden of disease, mortality, and inci-
dence rate of CCHF among males than females 
shows that animal husbandry and farming are a 
male job. Job is a risk factor for CCHF and those 
whose jobs are related to livestock are at risk of 
CCHF (1, 14). In addition, the infection rate of 
Crimean-Congo Hemorrhagic Fever Virus 
(CCHFV) in livestock is a strong predictor for 
determining the incidence of CCHF in countries 
like Iran (17) and Mauritania (18). However, it is 
not an important factor for the incidence of 
CCHF in Bulgaria, because in Bulgaria there is a 
proper program for the vaccination of population 
at risk such as ranchers and veterinarians (19).  
The two factors of climate and job are the main 
predictors of CCHF (20, 21). Therefore, the dis-
tribution and burden of CCHF may vary in dif-
ferent parts of the country. It is important to un-
derstand the geographical distribution of CCHF 
as well as its real risk in order to increase public 
awareness, enhance safety programs for health 
personnel, ranchers, and slaughterhouse workers, 
and improve protective measures against tick 
bites (22).  
Based on the results of our study, between 2009 
and 2015, the presence of patients with CCHF 
was reported in 29 out of the 31 provinces of the 
country. The results of our study revealed that 
the burden of CCHF was different in various 
provinces of Iran and it did not have an equal 
distribution; a large share of DALYs is observed 
in only a few numbers of provinces. Authorities 
need to pay more attention to provinces such as 
Sistan and Baluchistan, Fars, Kerman, Yazd, and 
Golestan if they want to prevent and control 
CCHF. In similar studies in other countries, there 
was no equal geographical distribution of CCHF 
in different parts of a country (7, 23, 24). 
According to other studies carried out in Iran 
(20) and Senegal (25), the incidence rate of 
www.SID.ir
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CCHF is high in areas suffering from the short-
age of rain and humidity for long periods. More-
over, high temperature has also been reported as 
a predictor of CCHF in Turkey (23), Bulgaria 
(19), and Iran (20). In Kosovo, the incidence of 
CCHF did not have a uniform distribution in all 
its provinces (14). The high prevalence of live-
stock farming and agricultural jobs, the suitable 
weather conditions, and shared borders with 
countries such as Turkey, Pakistan, Afghanistan, 
and Iraq have turned Iran into an ideal ecosystem 
for CCHF. The current status of CCHF disease 
in Iran indicates the need to seriously focus on 
different aspects of this disease; for instance, it is 
necessary to identify high-risk areas, practice early 
diagnosis and intervention, manage patients, de-
velop vaccines, control, and fight tick, and screen 




As one of the limitations of our study, we only 
used the data collected form CCHF surveillance 
system to estimate the incidence, mortality, and 
burden of the disease. CCHF surveillance system, 
similar to other surveillance systems implemented 




CCHF is an indigenous disease. In recent years, 
there have been some cases of this disease, espe-
cially in some specific areas of Iran. Apparently, 
there is no effective program in the country to 
control the spread of this disease in livestock; 
therefore, it is expected to observe more cases of 
CCHF in the future. Monitoring the incidence 
and burden of the disease over time can show the 
effect of interventions implemented to control 
the disease. Thus, it is highly recommended to 
conduct such studies. Given the high CCHF 
mortality rate and its negative effects on livestock 
industry, authorities should pay more attention to 
this disease. Empowering the CCHF surveillance 
system and implementing effective interventions 
to prevent virus transmission from livestock to 
human are the most important measures fully 
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